One of the most common birth defects worldwide is hearing loss. Every 1,000 babies born worldwide are affected by permanent hearing loss in one or both ears. Hearing loss can significantly affect a baby's development.
CapitalBiotech has developed the Hereditary Deafness Gene Detection Assay using semiconductor sequencing technology. It can identify 100 mutant sites on 18 deafness-related genes such as GJB2, SLA26A4, GJB3, MT-RNR1, and others. This detection assay boasts an accuracy of over 99.9%.
The BioElectron Gene Squencer 4000 platform was developed in collaboration with Thermo Fisher. It can detect 384 samples simultaneously.
What Are the Diagnostic Methods for Breast Cancer?April 4, 2023Breast cancer has become a terrifying disease that kills female friends with increasing clinical incidence rate. It not only harms women's health but also has a great impact on our normal life. So...view
Major Benefits of Using Next Generation Sequencing PlatformsApril 2, 2026Next Generation Sequencing (NGS) platforms have revolutionized genomics by providing high-throughput, accurate, and cost-effective solutions for genetic research. These platforms have opened up new po...view
Struggling to Lose Weight? Obesity Genetic Test May Reveal WhyNovember 13, 2024Obesity Genetic Test: Making Your Weight Loss Efforts More EffectiveWhy do some people find it very difficult to lose weight? And why do some people rarely gain weight regardless of how much they eat?...view